Key result
Intravenous ATP unmasks dormant superior vena cava conduction to guide successful ablation in silent AF.
Why the study?
Non-pulmonary vein triggers of atrial fibrillation, including those in the superior vena cava, have unpredictable inducibility and are difficult to identify.
Can intravenous ATP unmask dormant superior vena cava-right atrial conduction and non-pulmonary vein triggers in patients with recurrent atrial fibrillation?
Case Report (n=1)
No
Can intravenous ATP unmask dormant superior vena cava-right atrial conduction and non-pulmonary vein triggers in patients with recurrent atrial fibrillation?
This case highlights that intravenous ATP administration can successfully unmask electrically silent SVC potentials and induce AF, serving as a valuable technique to identify non-pulmonary vein triggers during repeat ablation.
Atrial fibrillations (AF) can originate from the pulmonary veins (PVs), and globally, PV isolation has been established as a treatment method of choice for AF.1 However, approximately 20% of AF cases are triggered by non-PV origins,2,3 including those in the superior vena cava (SVC). However, the inducibility of non-PV triggers is unpredictable, and AF triggers are difficult to identify. Adenosine triphosphate (ATP) can unmask dormant conduction between the SVC and the right atrium (RA) after ablation and between the PVs and the left atrium (LA).
No takes yet. Share an insight, caveat, or question.
Fujisawa et al. (2022) conducted a case report in Paroxysmal atrial fibrillation (n=1). Intravenous adenosine triphosphate (ATP) was evaluated on Induction of AF firing and dormant superior vena cava-right atrium (SVC-RA) conduction from a silent SVC. Intravenous ATP provoked venoatrial conduction and AF firing from an electrically silent superior vena cava, guiding successful ablation without recurrence at 1 year.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: